Research Analysts
Dr. Echo Yinghui He, MD PhD
Senior Equity Analyst
China
Prior to joining Maxim Group, Dr. He was a Director at Oppenheimer & Co (former CIBC, Equity Research) where she conducted equity analysis of small-to-mid cap US-listed Chinese stocks. Previous to Oppenheimer & Co., Dr. He served as a Vice President at CRT Capital Group where she conducted equity and credit analysis of Chinese small-cap, US life science and distressed companies. Dr. He also served as a research scientist at the National Institutes of Health (NIH) where she conducted a part of the Human Genome Project aimed at interpreting diseases and their risks by genetic patterns.
Dr. He received a M.D. from Beijing University, a PhD in Medical Sciences from the University of Toledo and a M.B.A. in Finance and Economics from the University of Chicago.